- Home
- REKR vs NTHI Comparison
REKR vs NTHI Comparison
Compare REKR & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REKR | NTHI |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.5M | 193.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REKR | NTHI |
|---|---|---|
| Price | $1.35 | $8.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 51.3K |
| Earning Date | 11-13-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $49,028,000.00 | $59,990.00 |
| Revenue This Year | $11.82 | N/A |
| Revenue Next Year | $22.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.89 | N/A |
| 52 Week Low | $0.62 | $3.20 |
| 52 Week High | $3.42 | $25.00 |
Technical Indicators
Market Signals| Indicator | REKR | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 33.55 | 51.19 |
| Support Level | $1.33 | $7.99 |
| Resistance Level | $1.79 | $9.07 |
| Average True Range (ATR) | 0.08 | 0.76 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 4.37 | 36.03 |
Price Performance
Historical ComparisonAbout REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).